Elanco Animal Health (ELAN) Amortization of Goodwill (2023)

Elanco Animal Health (ELAN) reported Amortization of Goodwill of $1.0 billion for Q3 2023.

Elanco Animal Health (ELAN) Amortization of Goodwill (2023) Analysis & Trends

Elanco Animal Health (ELAN) has 1 years of Amortization of Goodwill data on file, last reported at $1.0 billion in Q3 2023.

  • For the quarter ending Q3 2023, Amortization of Goodwill changed N/A year-over-year to $1.0 billion; the trailing twelve-month figure through Dec 2024 stood at $1.0 billion (changed N/A YoY), and the FY2023 full-year result was $1.0 billion, changed N/A from the prior year.
  • Amortization of Goodwill was little changed at $1.0 billion in Q3 2023.
  • In the past five years, Amortization of Goodwill ranged from a high of $1.0 billion in Q3 2023 to a low of $1.0 billion in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn

Historic Data

Download Data
DateValue
Sep 30, 2023 1.04 Bn
Sep 30, 2023 1.04 Bn